EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

RBSP3 is frequently altered in premalignant cervical lesions: clinical and prognostic significance



RBSP3 is frequently altered in premalignant cervical lesions: clinical and prognostic significance



Genes, Chromosomes & Cancer 49(2): 155-170



To understand the importance of frequent deletion of 3p22.3 in cervical carcinogenesis, alterations (deletion/methylation/expression) of the candidate genes STAC, MLH1, ITGA9, and RBSP3, located in the region, were analyzed in 24 cervical intraepithelial neoplasia (CIN) and 137 uterine cervical carcinoma (CACX) samples. In CIN, RBSP3 deletion (48%) and methylation (26%) were high compared with the other genes (4-9%). In CACX, alterations of these genes were as follows: deletion: STAC (54%) > MLH1 (46%) > RBSP3 (45%) > ITGA9 (41%), methylation: RBSP3 (25%) > ITGA9 (24%) > STAC (19%) > MLH1 (13%). Overall, alterations of RBSP3 showed association with CIN, whereas for STAC and MLH1, this frequency increased significantly from CIN --> Stage I/II and for ITGA9 from CIN --> Stage I/II and also from Stage I/II --> Stage III/IV. Quantitative mRNA expression analysis showed differential reduced expression of these genes in CACX concordant to their molecular alterations. The more active RBSP3B splice variant was underexpressed in CACX. RB1 was infrequently deleted in CACX. Concordance was seen between (i) inactivation of RBSP3 and intense p-RB1 nuclear immunostaining and (ii) low/absence of MLH1 expression and its molecular alterations in CACX. In normal cervical epithelium, p-RB1 immunostaining was low in differentiated cells, whereas MLH1 staining was seen in both nucleus and cytoplasm irrespective of differentiation stage. Alterations of the genes were significantly associated with poor prognosis. High parity (>or=5)/early sexual debut (

(PDF emailed within 0-6 h: $19.90)

Accession: 055333697

Download citation: RISBibTeXText

PMID: 19885927

DOI: 10.1002/gcc.20726



Related references

Alterations of RASSF1A in premalignant cervical lesions: clinical and prognostic significance. Molecular Carcinogenesis 51(9): 723-733, 2012

Frequent alterations of the candidate genes hMLH1, ITGA9 and RBSP3 in early dysplastic lesions of head and neck: clinical and prognostic significance. Cancer Science 101(6): 1511-1520, 2010

The clinical significance of HPV screening in premalignant cervical lesions. European Journal of Gynaecological Oncology 31(5): 596-597, 2010

Discovery of regions on 8q and 13q frequently altered in oral premalignant lesions and tumors. Proceedings of the American Association for Cancer Research Annual Meeting 43: 294, March, 2002

Expression of the HPV18E2 gene in cervical cancer and premalignant lesions and its clinical significance. Cell Biochemistry and Biophysics 70(2): 841-844, 2015

Clinical management of premalignant lesions of the prostate. WHO Collaborative Project and Consensus Conference on Public Health and Clinical Significance of Premalignant Alterations in the Genitourinary Tract. Scandinavian Journal of Urology and Nephrology. Supplementum: 44-49, 2001

Frequent alterations of hMLH1 and RBSP3/HYA22 at chromosomal 3p22.3 region in early and late-onset breast carcinoma: clinical and prognostic significance. Cancer Science 99(10): 1984-1991, 2008

Prognostic significance of co-overexpression of bcl-2 and c-erbB-2/neu in uterine cervix carcinomas and premalignant lesions. Medicinski Glasnik 9(2): 248-255, 2012

Tissue CEA in premalignant epithelial lesions and epidermoid carcinoma of the uterine cervix: prognostic significance. International Journal of Cancer 23(4): 448-453, 1979

LIMD1 is more frequently altered than RB1 in head and neck squamous cell carcinoma: clinical and prognostic implications. Molecular Cancer 9(): 58-58, 2010

Inactivation of SLIT2-ROBO1/2 pathway in premalignant lesions of uterine cervix: clinical and prognostic significances. Plos One 7(6): E38342-E38342, 2012

Expression and clinical significance of IMP3 in microdissected premalignant and malignant pancreatic lesions. Clinical & Translational Oncology 17(3): 215-222, 2016

Expression of p53 protein and PCNA in premalignant lesions of oral mucosa and its clinical significance. Shanghai Kou Qiang Yi Xue 8(1): 18-20, 2004

Clinical significance of aberrant vimentin expression in oral premalignant lesions and carcinomas. Oral Diseases 20(5): 453-465, 2015

Telomerase activity in gastric cancer and premalignant lesions: determination and its clinical significance. Zhonghua Yi Xue Za Zhi 78(3): 207-209, 2000